Navigating MHRA inspections requires a proactive approach, strategic preparation & a deep understanding of evolving regulatory expectations. We discuss how to streamline inspection readiness & enhance compliance outcomes with these innovative strategies. hubs.ly/Q03pCdb20

Last call! Join our webinar this week to gain practical insights from Cytel’s MHRA inspection experience. Learn how to prepare thoroughly, execute precisely, and turn post-inspection feedback into innovation. Register here: bit.ly/4km9uCy

The future of CNS clinical trials is increasingly adaptive, digital, and data driven. We discuss 3 recent case studies that exemplify innovations in clinical trial design for CNS disorders and proposes statistical advancements to strengthen their impact.bit.ly/455f2N7

If you're headed to PCMG 2025 next week, make sure to connect with our colleagues to discover how we are empowering life science leaders to realize the full potential of their therapies! Book your meeting here: bit.ly/43YncWu #PCMG #ClinicalTrials

Clinical data science is evolving rapidly, and CDISC EU and PHUSE-CSS offer a glimpse into the future of regulatory submissions, standardization, and the rise of open-source tools and AI in drug development. Here are the key takeaways: bit.ly/4ksawgo

We're excited to announce that our CSO Yannis Jemiai will be a panel member at the BIO International Convention in Boston on "AI-Powered Clinical Trials: Transforming Drug Development in the US" #AI #ClinicalTrials #DrugDevelopment

After a great first day at PSI with some great conversations and two insightful presentations by Valeria Mazzanti and Flaminia Chiesa, the team is ready for day 2! Make sure to drop by booth 4! #PSI #EastHorizon #AI #Rcoding

Data monitoring committees, which review #data from ongoing trials & make recommendations like stopping for futility or efficacy, yield significant value for #clinical programs. We share 10 key ways to maximize that value and ensure a cost-effective #DMC. hubs.ly/Q03rGDDl0

The Cytel Team is looking back at a great PSI 2025 at beautiful Wembley Stadium! Great talks and amazing insights from all present there, not in the least from our very own Valeria Mazzanti and Flaminia Chiesa! See you all next year! #PSI2025 #PSI 2026

Agile promotes adaptability, efficiency & collaboration. We discuss how, with #Agile, statistical programmers can deliver high-quality #software faster while continuously improving processes: hubs.ly/Q03rNg7J0

Clinical trials are always evolving, but one thing stays the same: quality data is key to faster approvals and better treatments for patients. We share simple, effective ways to protect your data’s accuracy and credibility. hubs.ly/Q03sqg0t0

As the demand for clinical biometrics support continues to grow, pharma companies are increasingly turning to global delivery models to access broader talent pools, meet timelines & stay within budget. We share best practices for sponsors: hubs.ly/Q03sqynC0

Traditional HTA frameworks have historically overlooked equity considerations and addressing this gap has become a growing concern. We discuss CAR T-cell therapies as a case study for better understanding and advancing equity considerations in #HTA. hubs.ly/Q03srvkY0

Clinical data managers play a key role in #clinicaltrials, ensuring the integrity of clinical #data and preparing the data for #statistical analysis. Sheree King and Abhishek Joshi discuss how #AI can accelerate clinical trial data management: hubs.ly/Q03t1N_x0

The probability of success of a study is a critical metric in assessing the viability of a study design. We discuss 4 key tools in the statistician’s toolbox to assess clinical trial design strength: power, assurance, and performance and robustness scores. hubs.ly/Q03t1WX90

The USP is developing a new chapter to address quality attributes in pharmaceutical suspensions to ensure consistent dosing and therapeutic efficacy. Bengt Hedin discusses how these new guidelines can help compliance with regulatory standards: hubs.ly/Q03tm09j0

Joe Maginnity, Biostatistician II, shares insights into the collaborative nature of his role as a biostatistician in DMCs and how biostatistics is evolving alongside advances in AI and machine learning. hubs.ly/Q03tGkpR0 #CytelWithoutQuestion #CareerPerspectives

We are excited to announce that our very own Angelo Tinazzi has been selected as the PHUSE EU Connect Co-Chair for 2025 AND for 2026! Make sure to connect with him in November when attending PHUSE EU Connect 2025 in beautiful Hamburg!

To improve the reliability of ITC results, sponsors often consult KOLs. But their role remains unstructured in formal guidance. We discuss the need for guidelines that outline when & how to integrate KOL input for better-informed healthcare decision-making.bit.ly/4kvlEZk

Smartwatches have emerged as promising tools in clinical trials to enhance efficiency and data quality. Manuel Cossio discusses their role in capturing digital primary endpoints and key findings from an analysis of 87 trials using Apple Watch technology. bit.ly/3GgEm94